Sign In
Buy NAV
$44.50
+0 (+0%)
At Close: Dec 08, 2021
Herzfeld Caribbean Basin Fund Has A Timely Path To Trade At NAV Or Better
05:18am, Monday, 25'th Nov 2024
Herzfeld Caribbean Basin Fund is at a crossroads, with over 70% of shareholders seeking an exit from the current strategy. 31.2% NAV decline in 2023 Rights Offering was needed for shareholder voting o
Prospect Capital: Out Of The Woods Or Back To The Woodshed?
07:00am, Saturday, 16'th Nov 2024
Prospect Capital Corporation's recent 25% dividend cut, despite previous ample coverage, raises concerns about future dividend reliability amid high interest rates and NAV erosion. PSEC's low leverage
Firsthand Technology Value Fund Announces Third Quarter Financial Results, NAV of $0.22 Per Share
04:15pm, Thursday, 14'th Nov 2024
SAN JOSE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantec
MONTCLAIR, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital” and the “Company”), today reported its financial results as of September 30, 202
Ares Capital: A Strong Q3 With Income Peak Likely Behind Us
05:27am, Tuesday, 12'th Nov 2024
Ares Capital delivered a solid 3.3% total NAV return, trades at a 9.2% dividend yield, and has a core earnings yield of 11.1%. The NAV rose to a record $19.77, marking the seventh consecutive quarterl
SLR Investment: Consistent Performer But Lacks NAV Growth
04:46am, Tuesday, 12'th Nov 2024
SLR Investment's diverse debt investment portfolio and low non-accrual rate indicate strong underwriting quality and resilience in a high interest rate environment. Despite a 10% dividend yield, thin
Icahn Enterprises: Longstanding NAV Premium
12:07pm, Saturday, 09'th Nov 2024
IEP trades at a premium to its NAV, even the NAV that the company proposes. The dividend getting cut may actually be relatively welcome news to a value investor assuming that this is a good moment to
Prospect Capital: 12% Yield And 45% Discount To NAV After Cut
05:37pm, Friday, 08'th Nov 2024
We had rated Prospect Capital with a Buy and also suggested it as an alternative to another weak BDC. The company cut its distribution today and sent the stock hurling 15% lower. The stock now yields
Blue Owl Capital Corporation III Reports Third Quarter Net Investment Income Per Share of $0.41 and Net Asset Value Per Share of $15.49
04:37pm, Wednesday, 06'th Nov 2024
NEW YORK , Nov. 6, 2024 /PRNewswire/ -- Blue Owl Capital Corporation III (NYSE: OBDE, or the "Company") today announced financial results for its third quarter ended September 30, 2024. THIRD QUARTER
Blue Owl Capital Corporation Reports Third Quarter Net Investment Income Per Share of $0.47 and Net Asset Value Per Share of $15.28
04:37pm, Wednesday, 06'th Nov 2024
NEW YORK , Nov. 6, 2024 /PRNewswire/ -- Blue Owl Capital Corporation (NYSE: OBDC, or the "Company") today announced financial results for its third quarter ended September 30, 2024. THIRD QUARTER 202
Oxford Lane Capital Q2 Earnings: High Activity Levels Overshadowed By NAV Decline
08:30am, Monday, 04'th Nov 2024
Oxford Lane Capital is a closed end fund that invests in CLO equity and to a lesser extent, debt. OXLC recently reported earnings for fiscal Q2. The fund was remarkably active during the quarter firin
Tetragon Financial Group Limited September 2024 Monthly Factsheet
02:55am, Thursday, 31'st Oct 2024
LONDON , Oct. 31, 2024 /PRNewswire/ -- Tetragon has released its Monthly Factsheet for September 2024. Net Asset Value: $3,016m Fully Diluted NAV Per Share: $33.85 Share Price (TFG NA): $10.20 Monthl
SLR Investment: 11% Yield, 15% Discount From NAV Make It A Buy
10:00am, Sunday, 27'th Oct 2024
SLR Investment Corp. offers a resilient portfolio with a 10.6% dividend yield, primarily composed of first-lien secured loans and specialty finance sectors, enhancing risk-adjusted returns. Despite la
Boston Scientific Shares Likely to Gain After FARAWAVE NAV Approval
12:40pm, Monday, 21'st Oct 2024
BSX receives FDA approval for the FARAWAVE NAV Ablation Catheter and FARAVIEW Software, enhancing cardiac mapping and ablation workflows for AF treatment.
Capital Southwest: Strong Portfolio But NAV Growth Can Be Improved
08:37am, Sunday, 20'th Oct 2024
I maintain a hold rating on Capital Southwest due to its high premium to NAV and lack of recent NAV growth. CSWC's portfolio is strong, with 88.9% in first lien senior secured debt and diverse industr
